Peter C. Van Bodegom
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Cancer Genomics and Diagnostics
Papers in ⓘ
-
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
- Tracheal and airway disorders 2
- Oncology 4
- Lung Cancer Research Studies 3
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Sjoerd Rodenhuis (1 shared paper)Robbert J.C. Slebos (1 shared paper)W. J. Mooi (1 shared paper)S S Wagenaar (2 shared papers)Siegina G. Evers (1 shared paper)Johannes L. Bos (1 shared paper)R.G.J.R.A. Vanderschueren (3 shared papers)Sjoerd Sc. Wagenaar (2 shared papers)
- Journals
- Cancer (1 paper)Immunology Letters (1 paper)Supportive Care in Cancer (1 paper)Lung Cancer (1 paper)Thorax (1 paper)
- Partner nations
- NetherlandsGermany
In The Last Decade
Peter C. Van Bodegom
9 papers receiving 595 citations
Peers
Comparison fields: 5 of 60
- Oncology 315
- Cancer Research 148
- Pulmonary and Respiratory Medicine 310
- Molecular Biology 245
- Neurology 51
Countries citing papers authored by Peter C. Van Bodegom
This map shows the geographic impact of Peter C. Van Bodegom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Van Bodegom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Van Bodegom more than expected).
Fields of papers citing papers by Peter C. Van Bodegom
This network shows the impact of papers produced by Peter C. Van Bodegom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Van Bodegom. The network helps show where Peter C. Van Bodegom may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Van Bodegom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. | 1988 | 386 |
| 2 | 1989 | 83 | |
| 3 | 1991 | 79 | |
| 4 | 1989 | 42 | |
| 5 | 1986 | 26 | |
| 6 | 1993 | 4 | |
| 7 | 1991 | 3 | |
| 8 | [5 cases of reactive arthritis following a Shigella flexneri epidemic in the Netherlands]. | 1985 | 1 |
| 9 | Quantitative pathologic analysis of first and second primary cancers in double tumors of the lung. | 1989 | 1 |
About Peter C. Van Bodegom
Peter C. Van Bodegom is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Surgery and Molecular Biology, having authored 9 papers that have together received 625 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (3 papers), Tracheal and airway disorders (2 papers), Neuroblastoma Research and Treatments (1 paper), Multiple and Secondary Primary Cancers (1 paper), Cancer therapeutics and mechanisms (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Oncology (315 citations), Cancer Research (148 citations), Pulmonary and Respiratory Medicine (310 citations), Molecular Biology (245 citations) and Neurology (51 citations). Peter C. Van Bodegom has collaborated with scholars based in Netherlands and Germany. Frequent co-authors include Sjoerd Rodenhuis, Robbert J.C. Slebos, W. J. Mooi, S S Wagenaar, Siegina G. Evers, Johannes L. Bos, R.G.J.R.A. Vanderschueren, Sjoerd Sc. Wagenaar, B Corrin and J. P. A. Baak. Their work appears in journals such as Cancer, Immunology Letters, Supportive Care in Cancer, Lung Cancer and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.